Literature DB >> 19528505

Association of polymorphisms in Tumor Necrosis Factor Alpha and Beta genes with increased risk for oral cancer.

Christos Yapijakis1, Zoe Serefoglou, Antonis Vylliotis, Emeka Nkenke, Spyridoula Derka, Stavros Vassiliou, Dimitrios Avgoustidis, Friedrich Wilhelm Neukam, Efstratios Patsouris, Eleftherios Vairaktaris.   

Abstract

BACKGROUND: In light of the recently found contribution of inflammation-related factors to oral oncogenesis, the possible correlation of tumor necrosis factor alpha and beta genes (TNF-alpha and TNF-beta) with risk of oral cancer was investigated.
MATERIALS AND METHODS: DNA samples of 160 German and Greek patients with oral squamous cell carcinoma and 153 healthy controls of equivalent age, gender and ethnicity were studied. The functional polymorphisms TNF-alpha (-308 G/A) and TNF-beta (252 G/A), which affect gene expression, were investigated by restriction fragment length polymorphism analysis.
RESULTS: The frequencies of high expression A2 (-308A) TNF-alpha allele and high expression B1 (252G) TNF-beta allele were significantly increased in cancer patients compared to controls (respectively: 62.2% versus 14.7%, p<0.0001; OR 8.65, 95% CI 5.74-13.04 and 66.9% versus 15.7%, p<0.0001; OR 10.92, 95% CI 7.4-16.2). Three combined TNF-alpha/TNF-beta genotypes (A2A2/B1B1, A1A2/B1B2, A1A2/B1B1) were over-represented in cancer patients (p<0.001). No significant differences in allele frequencies were detected among most subgroups of patients divided in regard to cancer stage, family history for cancer or thrombosis, smoking or heavy alcohol consumption habits.
CONCLUSION: This study showed a strong association of TNF-alpha and TNF-beta high expression alleles with increased risk of oral cancer. These findings are in accordance with previously observed high TNF-alpha levels in serum of patients with oral cancer in comparison to healthy controls.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19528505

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  19 in total

1.  Genetic variants in TNF-α promoter are predictors of recurrence in patients with squamous cell carcinoma of oropharynx after definitive radiotherapy.

Authors:  Caiyun Zhang; Erich M Sturgis; Hongliang Zheng; Xicheng Song; Peng Wei; Lei Jin; Li Chao; Qingyi Wei; Guojun Li
Journal:  Int J Cancer       Date:  2013-10-24       Impact factor: 7.396

2.  Association of Interleukin-10 (A1082G) gene polymorphism with Oral squamous cell carcinoma in north Indian population.

Authors:  Syed Rizwan Hussain; Mohammad Kaleem Ahmad; Abbas Ali Mahdi; Hena Naqvi; Mohammad Waseem Ahmad; Saurabh Srivastava; Kumud Nigam; Shalini Gupta
Journal:  J Genet       Date:  2016-06       Impact factor: 1.166

3.  Polymorphisms in the TNF-α and IL10 gene promoters and risk of arsenic-induced skin lesions and other nondermatological health effects.

Authors:  Nilanjana Banerjee; Sujay Nandy; James K Kearns; Apurba K Bandyopadhyay; Jayanta K Das; Papiya Majumder; Santanu Basu; Saptarshi Banerjee; Tanmoy Jyoti Sau; J Christopher States; Ashok K Giri
Journal:  Toxicol Sci       Date:  2011-02-25       Impact factor: 4.849

4.  Effect of a functional variant of tumor necrosis factor-β gene in temporomandibular disorders: A pilot study.

Authors:  Kaan Yerliyurt; Ayse Feyda Nursal; Akin Tekcan; Nevin Karakus; Mehmet K Tumer; Serbulent Yigit
Journal:  J Clin Lab Anal       Date:  2018-08-20       Impact factor: 2.352

5.  TNF-α promoter polymorphisms and risk of recurrence in patients with squamous cell carcinomas of the nonoropharynx.

Authors:  Caiyun Zhang; Erich M Sturgis; Hongliang Zheng; Mark E Zafereo; Qingyi Wei; Guojun Li
Journal:  Int J Cancer       Date:  2014-02-27       Impact factor: 7.396

6.  TNF-β +252 A>G polymorphism and susceptibility to cancer.

Authors:  Lin Yang; Rennan Feng; Guiyou Liu; Mingzhi Liao; Liangcai Zhang; Wenbo Wang
Journal:  J Cancer Res Clin Oncol       Date:  2013-02-03       Impact factor: 4.553

7.  Positive association between lymphotoxin-alpha variation rs909253 and cancer risk: a meta-analysis based on 36 case-control studies.

Authors:  Xi Yu; Yi Huang; Changhong Li; Hailian Yang; Caide Lu; Shiwei Duan
Journal:  Tumour Biol       Date:  2013-10-18

8.  Impacts of TNF-LTA SNPs/Haplotypes and Lifestyle Factors on Oral Carcinoma in an Indian Population.

Authors:  Kapil Bandil; Pallavi Singhal; Upma Sharma; Showket Hussain; Surojit Basu; Aditya Parashari; Veena Singh; Ashok Sehgal; Animesh Shivam; Puneet Ahuja; Mausumi Bharadwaj; Basu Dev Banerjee; Ravi Mehrotra
Journal:  Mol Diagn Ther       Date:  2016-10       Impact factor: 4.074

9.  TNFRSF1B A1466G genotype is predictive of clinical efficacy after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.

Authors:  Akiko Kuwahara; Motohiro Yamamori; Megumi Fujita; Tatsuya Okuno; Takao Tamura; Kaori Kadoyama; Noboru Okamura; Tsutomu Nakamura; Toshiyuki Sakaeda
Journal:  J Exp Clin Cancer Res       Date:  2010-07-20

10.  Association of tumor necrosis factor-alpha promoter variants with risk of HPV-associated oral squamous cell carcinoma.

Authors:  Lei Jin; Erich M Sturgis; Yang Zhang; Zhigang Huang; Xicheng Song; Chao Li; Qingyi Wei; Guojun Li
Journal:  Mol Cancer       Date:  2013-07-19       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.